Answers are grounded in this paper and cite their sources.
Prospective cohort study examines the effects of protein C and S deficiency on outcomes in adult cerebral venous sinus thrombosis, indicating distinct clinical features.
Background Protein C and S (PC/PS) deficiency is a recognized thrombophilia risk factor for cerebral venous sinus thrombosis (CVT), but its effect on disease prognosis remains unclear. We examined clinical characteristics and long-term outcomes in adult patients with CVT, comparing those with and without PC/PS deficiency. Methods In this prospective exploratory cohort study, 61 adult patients with newly diagnosed CVT between January 2024 and August 2025 were enrolled and followed up for 12 months. PC/PS deficiency was defined as antigen or activity levels < 66% of normal. Genetic testing for mutations in the PROC (PC gene) and PROS1 (PS gene) loci was conducted in 8 patients with PC/PS deficiency. Clinical features, imaging findings, and functional outcomes were compared by PC/PS deficiency status. Study outcomes were disability defined as modified Rankin Scale (mRS) score at discharge, 3 and 12 months. Results Of 61 adult CVT patients, 12 (19.7%) had PC/PS deficiency. These patients were younger (mean age 33.3 vs. 45.6 years; P = 0.024), and had higher prevalence of prior venous thromboembolism (33.3% vs. 2.0%; P = 0.004) and seizures (50.0% vs. 8.2%; P = 0.002). Superior sagittal sinus thrombosis was more prevalent in the PC/PS-deficient group (91.7% vs. 42.9%; P = 0.003). No significant differences were observed between groups in terms of recanalization, parenchymal injury, or 12-month functional outcome (all P > 0.05). At 12 months, four patients (6.6%) had mRS ≥ 2, with no deaths reported. Conclusions PC/PS deficiency in adult CVT presented distinct clinical and anatomical features, including earlier onset, prior thrombosis, and superior sagittal sinus involvement. No differences in recanalization or long-term functional outcomes were observed by PC/PS status. However, due to limited sample size, the study could be underpowered for prognostic comparisons and should be interpreted with caution. Trial registration Chinese clinical trial registry URL: https://www.chictr.org.cn ; Unique identifier: ChiCTR2400080136; Registered 22 January 2024.
No takes yet. Share an insight, caveat, or question.
(52434) et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: